PRISM Stock Indexes
Current Value
% Change (Daily)
% Change (Inception)
Top % Gainers
% Change
Top % Losers
% Change (Inception)
Semiconductors $215.30 -2.3% 115.3% TRT  8.465% AAOI -8.139%
Pet Care $216.40 0.4% 116.4% BARK  5.146% JAGX -6.478%
Aerospace and Defense $155.10 -2.1% 55.1% VELO  13.317% ASTC -11.43%
AI Datacenter and Infrastructure $462.50 0.2% 362.5% OSS  11.51% RZLV -4.856%
Beauty and Wellness $71.50 0.2% -28.5% TRNR  11.82% LFVN -9.531%
Biotech $154.40 -0.4% 54.4% ONCY  11.409% KRRO -7.804%
Cannabis $102.60 -0.4% 2.6% HITI  12.667% TCNNF -14.632%
Comms and Media $181.20 0.2% 81.2% MGNI  8.076% SNAL -4.907%
Consumer Products $129.40 -0.8% 29.4% VNCE  36.782% SNBR -28.457%
Crypto Mining $270.30 3.2% 170.3% SLNH  19.032% ATNF -7.49%
Cybersecurity $142.80 0.3% 42.8% HUBC  14.881% ALAR -5.263%
EV $126.80 -1.5% 26.8% BEEM  15.254% MULN -19.735%
Fintech $104.20 1.9% 4.2% FTHM  38.891% ATON -6.838%
Global Health $113.30 0.7% 13.3% SGMO  7.576% GUTS -4.118%
Healthcare $108.10 0.4% 8.1% NVNO  6.399% BTCY -9.077%
NextGen Tech & AI $204.30 -0.4% 104.3% RXT  14.286% NRDY -8.535%
New Energy $155.50 1.5% 55.5% BWEN  21.086% LNZA -6.463%
MedTech Index $128.90 -0.5% 28.9% CTSO  17.083% BIAF -24.453%
Mental Health $83.10 1% -16.9% VTGN  20.209% ITRM -10.979%
Oil & Gas $109.70 -0.9% 9.7% TPET  5.575% ICD -9.877%
Pharmaceuticals $254.90 0.5% 154.9% KALA  13.636% ATHA -6.12%
Precious Metals $273.00 1.1% 173.0% SSRM  10.401% CRML -5.447%
Psychedelics $225.90 -1.7% 125.9% ATAI  4.818% HUGE -10.1%
Space $495.70 -1.7% 395.7% AMPG  15.6% PL -8.273%
Sports $122.40 -1.2% 22.4% LTRY  6.202% FUBO -8.115%
Weight Loss $164.20 -0.4% 64.2% VKTX  1.96% MED -3.099%
Women’s Health $156.50 -2% 56.5% NVCT  4.619% AWH -15.897%
View All

PRISM View

PRISM Mid Day Movers: Fintech and Consumer Products are Todays Leaders.

Fathom Holdings Inc. (NASDAQ: FTHM) is having a strong session today, with the stock up about 28% to 0.5629 from a prior close of 0.4402. Shares have traded between 0.4501 and 0.65 on heavy volume of roughly 2.9 million, far above normal ac...

Steel River Energy Center: $3.5B Solar‑and‑Storage Giant Coming to Mississippi County

A 3.5 billion dollar solar‑plus‑storage “energy center†is coming to Mississippi County, Arkansas, and it’s big enough to matter both locally and for the regional power grid. The Steel River Energy Center, led by Cypress Creek Ene...

West Marine’s Bankruptcy: What Investors Should Really Take Away

West Marine closing nearly 60 stores under Chapter 11 looks less like a surprise and more like a long‑overdue reset for an overleveraged, over‑stored specialty retailer in a cyclical niche. This is the classic “too much debt, too many...

Dragonfly Energy Holdings Corp. Achieves Technical Milestone with New European Patent Allowance

Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) has received a formal patent allowance from the European Patent Office for its battery manufacturing methods. This international regulatory milestone for Dragonfly Energy Holdings Corp. (NASDAQ...

SpaceX Rockets 21% in Record Nasdaq Debut, Vaulting Past a $2 Trillion Valuation 

Elon Musk’s rocket and satellite venture stormed onto the public markets Friday, and investors wasted no time piling in. Shares of Space Exploration Technologies (SPCX) jumped 21% on their first day of trading, capping what now ranks as t...

PRISM Mid-Day Movers: New Energy and Fintech Are Today’s Leaders.

LanzaTech Global, Inc. (NASDAQ: LNZA) is trading solidly higher today, climbing about 16% to 7.2801 from a prior close of 6.25. Shares have moved between 6.3101 and 7.5601 on the session, with volume running above normal levels as investors...

Sharon AI Locks In 6‑Year NVIDIA Deal to Power 40,000 Blackwell GPUs in Australia

Sharon AI (NASDAQ: SHAZ) has signed a six‑year AI compute collaboration with NVIDIA to deploy up to 40,000 Grace Blackwell GB300 GPUs and 72MW of new AI data center capacity in Australia. The deal lifts Sharon AI’s total “AI factoryâ€...

Array Technologies Tops 100 GW: Solar Tracker Leader Hits Global Scale Milestone

Array Technologies (NASDAQ: ARRY) has surpassed 100 gigawatts of solar tracker deliveries worldwide, marking a major scale milestone for the company and the utility‑scale solar sector. The milestone reflects years of global execution acro...

OPEC Trims 2026 Oil Demand Outlook but Bets Bigger on 2027

OPEC dialed back its expectations for global oil demand this year, yet the cartel simultaneously raised its forecast for 2027 — a split-screen signal that reflects near-term caution and longer-term confidence. OPEC now projects that glob...

PRISM Mid-Day Movers: Space and Aerospace & Defense are Today’s Leaders.

Momentus Inc. (NASDAQ: MNTS) is rallying sharply today, with the stock up about 30% to 14.785 from a prior close of 11.34. Shares have traded in a wide intraday range between 11.15 and 15.88 on heavy volume of roughly 10.4 million, as inves...

Dana, Eaton Mobility in $5.1B Drivetrain Powerhouse Deal

Dana  Incorporated (NYSE: DAN) and Eaton Mobility are combining in a 5.1 billion dollar deal that will create a commercial‑vehicle supplier with more than 10 billion dollars in enterprise value and about 11 billion dollars in projected 2...

Eli Lilly Deepens Alzheimer’s Bet with AlzeCure Collaboration

Eli Lilly and Company (NYSE: LLY) has entered into a collaboration and out‑licensing agreement with Sweden‑based AlzeCure for global rights to Alzstatin ACD680, a preclinical small‑molecule candidate targeting Alzheimer’s disease. T...

Bio View

FDA Approves First OTC Glucose Monitor for Kids Gets Green Light

The FDA has cleared Dexcom’s (NASDAQ: DXCM) Stelo Glucose Biosensor System as the first over‑the‑counter continuous glucose monitor (CGM) that children can use, extending earlier OTC use in adults to kids as young as 2 who do not use ...

Legend Biotech Corporation Clinical Proof of Concept for Breakthrough CAR-T Therapy

Legend Biotech Corporation (NASDAQ: LEGN) achieved a major technological milestone on June 14, 2026, by establishing clinical proof-of-concept for its novel oncology asset, LB2501. The clinical data demonstrates the early efficacy of this p...

Johnson & Johnson Commits Over 1 Billion Dollars to Expand Florida Vision Manufacturing

Johnson & Johnson (NYSE: JNJ) announced a capital allocation plan exceeding $1 billion to expand its vision care manufacturing footprint in Jacksonville, Florida. This long-term financial commitment for Johnson & Johnson to scale ad...

Novartis and Orionis Double Down: 1.4B Molecular Glue Pact Targets “Undruggable†Diseases

Novartis (NYSE: NVS) has expanded its collaboration with Orionis Biosciences in a multi‑year molecular glue drug discovery deal that includes 40 million dollars upfront and up to 1.4 billion dollars in potential milestones plus royalties....

Parabilis Sets New Biotech IPO Bar with 670 Million Dollar Debut

Parabilis Medicines’ (NASDAQ: PBLS) Wall Street debut just reset the bar for biotech IPOs, with the cancer‑focused peptide company raising 670 million dollars in an upsized Nasdaq offering that tops even this year’s prior record from ...

Lexaria Advances Next-Generation GLP-1 Research With Completion of Dosing in New Animal Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) has completed dosing in its 2026 Animal Study #2 (GLP-1-A26-2), which is evaluating orally delivered formulations of two next-generation GLP-1 drugs, retatrutide and amycretin, using the company’s D...

Novanta’s 1.45 Billion Dollar Riverpoint Buyout Doubles Down on Surgical Consumables

Novanta Inc. (NASDAQ: NOVT) is making a big push deeper into minimally invasive surgery, agreeing to acquire Riverpoint Medical in a cash deal worth up to 1.45 billion dollars. For investors, the transaction is all about accelerating growth...

RedHill’s Opaganib Wins Key FDA Rare Pediatric Disease Designation for Neuroblastoma

RedHill Biopharma’s (NASDAQ: RDHL) oral drug candidate opaganib has received Rare Pediatric Disease (RPD) designation from the U.S. Food and Drug Administration for the treatment of neuroblastoma, adding another important regulatory incen...

Galmed’s 4.5 Million Dollar Colospan Deal Marks a New Chapter in Surgical Devices.

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is expanding beyond its traditional biotech focus with a small but strategic move into medical devices, agreeing to acquire Israeli surgical‑device company Colospan for about 4.5 million dollars....

Conexeu Sciences Steps Up as CXU Wound‑Care Device Nears the FDA Runway

Conexeu Sciences (NASDAQ: CNXU) stock is getting a lift as the company checks off key steps toward bringing its lead wound care device, CXU, into the clinic and eventually the market. For investors, the update shows that Conexeu Sciences I...

Roche’s New 2.3 Billion Dollar Bet on Nurix’s Blood Cancer Degrader

Roche Holding AG (OTC: RHHBY)  is making a major push deeper into targeted protein degradation, signing a deal worth up to 2.3 billion dollars with Nurix Therapeutics Inc. (NASDAQ: NRIX) for rights to an experimental blood cancer drug call...

Tango Therapeutics Stock Rockets on Standout Pancreatic Cancer Results

Tango Therapeutics Inc. (NASDAQ: TNGX) just delivered the kind of data that can reset a small‑cap oncology name, with shares soaring over 30% after new pancreatic cancer results showed a 92% objective response rate in treated patients. Th...

Q&A Corner

Opus Genetics: Advancing Gene Therapy and Ophthalmic Innovation with Major Milestones Ahead

Forward-Looking Statements This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning data from and fu...

Traders Lens

Quantum Corp.

$QMCO attempting to turn the $10 area from resistance into support.

$ZCASH is breaking out and if form holds, I see a target of around $830

$ZCASH is breaking out and if form holds, I see a target of around $830.

$ZCASH is breaking out and if form holds, I see a target of around $830.

Docusign, Inc.

$DOCU continuing to coil beneath the ~$50 resistance zone while putting in higher lows.

Cognex Corp.

$CGNX breaking above the long-term ~$55 resistance zone. Important level on the monthly chart.

MongoDB, Inc.

$MDB approaching the ~$270 resistance zone after the recent bounce. Key level coming up.

L3Harris Technologies

$LHX consolidating near the ~$335 support shelf while trading below the 50-day. Watching this level.

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup